Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
NATIONAL INSTITUTES OF HEALTH has floated a tender for Neuropathological Interactions between Covid-19 and Adrd (R01 - Clinical Trial not Allowed). The project location is USA and the tender is closing on 04 Oct 2023. The tender notice number is PAR-23-214, while the TOT Ref Number is 83987402. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country: USA
Summary: Neuropathological Interactions between Covid-19 and Adrd (R01 - Clinical Trial not Allowed)
Deadline: 04 Oct 2023
Other Information
Notice Type: Tender
TOT Ref.No.: 83987402
Document Ref. No.: PAR-23-214
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Tender are invited for Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders93.866 -- Aging Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Oct 04, 2023
Posted Date : Jun 06, 2023
Description: "This FOA will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following:- Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is already present (for example, in a model of AD/ADRD).- Mechanistic studies that address how COVID-19 accelerates AD/ADRD pathology and cognitive deficits in a prodromal model (early phase, pre-symptomatic).- Mechanistic studies that address how COVID-19 predisposes for AD/ADRD and/or interacts with relevant comorbid conditions and risk factors (cellular mechanisms that could potentially increase the risk for future AD/ADRD)."
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google